GARDEN CITY, NY - 专注于生物科技、基因组学和消费品的ProPhase Labs, Inc.（纳斯达克代码：PRPH）今日宣布任命Stu Hollenshead为首席运营官。根据 InvestingPro 数据显示，该公司目前市值为$7.76百万，正面临重大运营挑战，此次任命是公司加强消费者健康和保健产品战略布局的一部分。

Tuesday named Stu Hollenshead as Chief Operating Officer, marking a pivotal step in the company’s expansion into ...

Stu is a world-class operator who understands how to build and scale consumer-first businesses,” said Ted Karkus, CEO of ProPhase Labs. “The Company’s particular focus going forward will be ...

ProPhase Labs (PRPH) appointed Stu Hollenshead as COO. Following the sale of Pharmaloz Manufacturing, COO Jed Latkin has resigned and ...

专注于制药业务、目前市值816万美元的ProPhase Labs, Inc.宣布进行高管层变动，现任首席运营官 (COO) Jed Latkin即将离职，Stuart Hollenshead将接任新COO一职。此次人事变动紧随Pharmaloz Manufacturing, ...

Equities researchers at Diamond Equity lowered their FY2024 earnings per share estimates for shares of ProPhase Labs in a research report issued on Thursday, February 13th. Diamond Equity analyst H.

ProPhase Labs, Inc., a company specializing in pharmaceutical preparations with a current market capitalization of $8.16 million, has announced an executive shift with the departure of its current ...

Equities research analysts at StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Free Report) in a report released on Monday. The brokerage set a “sell” rating on the stock.

ProPhase Labs, Inc. Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company’s Balance Sheet and ...

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare ...